Consequently, this research focuses on a T-SPOT.TB study aiming to monitor T-SPOT before and after ICIs therapy to examine the impact of ICIs treatment on the outcomes of the interferon-gamma release assay and its diagnostic efficacy in NSCLC patients. The gene discussed is IFNG; the disease is tuberculosis.